Mike Polark

Q: What is Mike Polark's success rate?

Mike Polark currently has a success rate of 100.

Q: What is the average return of Mike Polark's calls?

Their stock ratings have generated an average return of 8.508895131086145.

Baird | Healthcare

Mike Polark is an analyst from Baird specializing in the Healthcare sector. Ranked #1624 out of 4773 analysts, they have issued 17 stock ratings with a success rate of 100.00% and an average return of 8.51%.

With 17 ratings to date, Mike Polark is beginning to establish credibility in the Healthcare sector. They have achieved a success rate of 100.00% and an average return of 8.51%, highlighting promising potential as their track record develops further.

#1624

Out of 4773

Total Ratings

+100.00%

Success Rate

+8.51%

Average Return

Recent Ratings Analysis

INSP

Hold

Aug 04, 2026

Target

$59.00

Current

$73.00

Performance

13.81%

Mike Polark rated INSP as Neutral on Aug 04, 2026, setting a price target of 59. Despite the Hold call, shares climbed 13.81% to 73, revealing unexpected momentum.

WAT

Buy

Jun 02, 2026

Target

$425.00

Current

$408.34

Performance

—

On Jun 02, 2026, WAT was given a Outperform rating by Mike Polark, with a target price of 425. The stock traded sideways with a % move, keeping the bullish thesis unresolved.

TMO

Buy

Jun 02, 2026

Target

$535.00

Current

$609.82

Performance

—

TMO received a Outperform rating from Mike Polark on Jun 02, 2026, aiming for 535. Price action was muted, as shares hovered around 609.82 despite the bullish outlook.

STVN

Buy

Jun 02, 2026

Target

$21.00

Current

$20.90

Performance

—

On Jun 02, 2026, Mike Polark published a Outperform outlook on STVN, with a target of 21. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 20.9.

RGEN

Buy

Jun 02, 2026

Target

$145.00

Current

$165.18

Performance

—

Mike Polark on Jun 02, 2026 assigned RGEN a Outperform rating, with a price target of 145. The recommendation remains pending validation as shares consolidate around 165.18.

NTRA

Buy

Jun 02, 2026

Target

$260.00

Current

$328.93

Performance

—

On Jun 02, 2026, Mike Polark reaffirmed NTRA with a Outperform rating, targeting 260. Market indecision has kept the 260 target in a holding pattern.

AVTR

Sell

Jun 02, 2026

Target

$7.00

Current

$14.81

Performance

—

AVTR was rated Underperform by Mike Polark on Jun 02, 2026, with a price objective of 7. The expected decline hasn’t materialized, as shares trade near 14.81.

GH

Buy

Jun 02, 2026

Target

$150.00

Current

$157.38

Performance

—

On Jun 02, 2026, Mike Polark initiated coverage on GH with a Outperform rating and target of 150. Neutral price movement of % leaves room for interpretation.

IRTC

Buy

Feb 20, 2026

Target

$220.00

Current

$111.43

Performance

-26.19%

Mike Polark issued a Outperform recommendation for IRTC on Feb 20, 2026, price target set at 220. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

MDLN

Buy

Jan 12, 2026

Target

$47.00

Current

$32.53

Performance

-23.85%

On Jan 12, 2026, MDLN was evaluated by Mike Polark, who gave a Outperform rating and target of 47. Investors saw limited payoff as shares fell short of the 47 target.

EW

Hold

Oct 29, 2025

Target

—

Current

$84.37

Performance

2.03%

Mike Polark rated EW as Peer Perform on Oct 29, 2025, setting a price target of null. The Hold stance appears justified, as shares hovered around 84.37 with a 2.03% move.

MDT

Hold

Jun 30, 2025

Target

—

Current

$90.96

Performance

4.35%

On Jun 30, 2025, MDT was given a Peer Perform rating by Mike Polark, with a target price of null. Market indecision, reflected in sideways trading near 90.96, supported the cautious call.

LIVN

Buy

May 20, 2025

Target

$60.00

Current

$78.18

Performance

74.20%

LIVN received a Outperform rating from Mike Polark on May 20, 2025, aiming for 60. Momentum has favored the Buy call, with shares climbing from 78.18 to 78.18, rewarding those who trusted the recommendation.

KMTS

Buy

Mar 31, 2025

Target

$29.00

Current

$22.85

Performance

-8.31%

On Mar 31, 2025, Mike Polark published a Outperform outlook on KMTS, with a target of 29. Market action contradicted the Buy thesis, as shares slipped to 22.85.

RMD

Sell

Sep 18, 2024

Target

$180.00

Current

$218.27

Performance

-8.30%

Mike Polark on Sep 18, 2024 assigned RMD a Underperform rating, with a price target of 180. Market strength contradicted the bearish call as shares gained -8.30%.

ISRG

Buy

Jul 19, 2024

Target

$503.00

Current

$369.15

Performance

-18.87%

On Jul 19, 2024, Mike Polark reaffirmed ISRG with a Outperform rating, targeting 503. Shares slid 18.87% despite the recommendation, highlighting downside risks.

PODD

Buy

May 07, 2024

Target

$200.00

Current

$131.96

Performance

-28.39%

PODD was rated Outperform by Mike Polark on May 07, 2024, with a price objective of 200. This case shows how bullish projections can fail, with the stock now below 131.96.

SWAV

Hold

Apr 05, 2024

Target

—

Current

$334.75

Performance

2.58%

On Apr 05, 2024, Mike Polark initiated coverage on SWAV with a Peer Perform rating and target of null. The stock’s lack of movement around 334.75 aligned with a cautious approach.

Frequency Asked Questions

Who is Mike Polark?

Mike Polark is an analyst from Baird specializing in the Healthcare sector.

What is Mike Polark's success rate?

Mike Polark currently has a success rate of +100.00%.

How many ratings has Mike Polark issued?

Mike Polark has issued 17 stock ratings so far.

What is the average return of Mike Polark's calls?

Their stock ratings have generated an average return of +8.51%.

What is Mike Polark's ranking?

Mike Polark is ranked #1624 out of 4773 analysts.

What types of ratings does Mike Polark give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Mike Polark?

You can follow Mike Polark by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Mike Polark?

Their latest rating was a Hold on INSP issued on 2026-08-04.